TYRA BIOSCIENCES INC (TYRA) — insider trading
Health Care · NASDAQ
TYRA BIOSCIENCES INC (TYRA) has 23 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 23 (latest 2026-09-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Rueb Yuliya | Officer (Vice President, Finance (PAO)) | Grant / award / vesting | 2,925 | $9.13 | $26.7K | Form 4 |
| 2026-09-15 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M. | Director, 10% owner | Open-market purchase (derivative) | 9,078,529 | $22.03 | $199.99M | Form 4 |
| 2026-09-15 | Harris Todd | Director, Officer (President and CEO) | Grant / award / vesting | 864 | $9.13 | $7.9K | Form 4 |
| 2026-09-15 | Fuhrman Alan | Officer (Chief Financial Officer) | Grant / award / vesting | 951 | $9.13 | $8.7K | Form 4 |
| 2026-09-09 | Verjee Rehan | Director | Open-market purchase | 972 | $20.58 | $20.0K | Form 4 |
| 2026-05-28 | Rothenberg Stephen Michael | Director | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-28 | MORE ROBERT J | Director | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-28 | Gulfo Adele M. | Director | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-28 | Simson Jake | Director | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-28 | Moran Susan | Director | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-28 | Verjee Rehan | Director | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-28 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M. | Director, 10% owner | Grant / award / vesting (derivative) | 13,160 | — | $0 | Form 4 |
| 2026-05-05 | Rueb Yuliya | Officer (Vice President, Finance (PAO)) | Grant / award / vesting (derivative) | 28,000 | — | $0 | Form 4 |
| 2026-05-05 | Rueb Yuliya | Officer (Vice President, Finance (PAO)) | Grant / award / vesting | 8,333 | — | $0 | Form 4 |
| 2026-05-05 | Ashar Bhavesh | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 50,295 | — | $0 | Form 4 |
| 2026-05-05 | Ashar Bhavesh | Officer (Chief Operating Officer) | Grant / award / vesting | 15,013 | — | $0 | Form 4 |
| 2026-05-05 | Harris Todd | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 265,000 | — | $0 | Form 4 |
| 2026-05-05 | Harris Todd | Director, Officer (President and CEO) | Grant / award / vesting | 79,000 | — | $0 | Form 4 |
| 2026-05-05 | Fuhrman Alan | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 67,000 | — | $0 | Form 4 |
| 2026-05-05 | Fuhrman Alan | Officer (Chief Financial Officer) | Grant / award / vesting | 20,000 | — | $0 | Form 4 |
| 2026-05-05 | Warner Douglas J | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 85,000 | — | $0 | Form 4 |
| 2026-05-05 | Warner Douglas J | Officer (Chief Medical Officer) | Grant / award / vesting | 25,000 | — | $0 | Form 4 |
| 2026-04-16 | Dable Habib J | Director | Grant / award / vesting (derivative) | 44,400 | — | $0 | Form 4 |
Ask the chat about TYRA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: TYRA BIOSCIENCES INC (TYRA).
Last updated 2026-09-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.